Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Jeeyun Lee
Journal Article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
The Oncologist, Volume 28, Issue 6, June 2023, Pages 553–e472, https://doi.org/10.1093/oncolo/oyad022
Published: 20 March 2023
Journal Article
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities
The Oncologist, Volume 25, Issue 1, January 2020, Pages e186–e193, https://doi.org/10.1634/theoncologist.2019-0221
Published: 06 September 2019
Journal Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
The Oncologist, Volume 24, Issue 11, November 2019, Pages 1462–1468, https://doi.org/10.1634/theoncologist.2019-0121
Published: 27 June 2019
Journal Article
Clinical Application of Targeted Deep Sequencing in Solid‐Cancer Patients and Utility for Biomarker‐Selected Clinical Trials
The Oncologist, Volume 22, Issue 10, October 2017, Pages 1169–1177, https://doi.org/10.1634/theoncologist.2017-0020
Published: 12 July 2017
Journal Article
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1306–1314, https://doi.org/10.1634/theoncologist.2016-0148
Published: 28 September 2016
Journal Article
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)
The Oncologist, Volume 20, Issue 11, November 2015, Pages 1312–1319, https://doi.org/10.1634/theoncologist.2015-0161
Published: 30 September 2015
